Publication
Presented on: September 29, 2020
Presented at: National Health Council’s annual Science of Patient Engagement Symposium (virtual)
Presented on: September 29, 2020
Presented at: National Health Council’s annual Science of Patient Engagement Symposium (virtual)
Presented on: September 23, 2020
Presented at: September Massachusetts Consortium on Pathogen Readiness Virtual Public Briefing
Presented on: September 22, 2020
Presented at: FDA Office of Minority Health and Health Equity webinar “Achieving Diversity, Inclusion, and Equity in Clinical Research”
Developed on: August 2020
Developed by: MRCT Center Diversity Workgroup
Published on: August 6, 2020
Published in: Healthcare: The Journal of Delivery Science and Innovation
Developed on: August 2020
Developed by: MRCT Center Diversity Workgroup
The MRCT Center Diversity Workgroup has developed a set of fundamental principles that help to frame considerations of diverse representation in clinical research. While we recognize that a case-based analysis will be required for each clinical research question, we also believe that these principles will help guide those analyses.
Developed on: August 2020
Developed by: MRCT Center Diversity Workgroup
There are practical and operational barriers that prevent routine participation of underrepresented, underserved, and diverse populations in clinical research. These must be addressed to promote change. While many challenges exist, for each section, we provide a key summary and recommendations to address appropriate representation in clinical research. Link to Resource >
Comments provided on: July 20, 2020
Comments provided to: Food and Drug Administration (FDA)
Comments provided on: June 29, 2020
Comments provided to: Food and Drug Administration (FDA)